Author

Margaret Ann Shipp

Broad InstituteORCID 0000-0002-3949-6897Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Approach:deep learning· 1 Assay:DNA methylation· 1

Frequent Co-Authors

Scott J. RodigiD· 2 shared Vignesh ShanmugamiD· 2 shared Abner LouissaintiD· 1 shared Alex K. ShalekiD· 1 shared Allison Tompkins· 1 shared Amy Y. HuangiD· 1 shared Anup VaidyaiD· 1 shared Arianna MarkeliD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Scott J. RodigORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCell Reports MedicinePeer-reviewedMar 31, 2026

Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment

Yao Yu Yeo, Huaying Qiu, Yunhao Bai…·Sizun Jiang

This study uses spatial multi-omics to compare EBV-positive and EBV-negative cHL, identifying distinct TME features and immunological signatures linked to EBV.

3 citations

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedDec 20, 2025

Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors

Vignesh Shanmugam, Neriman Tokcan, Daniel Chafamo…·Todd R. Golub

This study identifies IL13 as a survival factor for Hodgkin lymphoma cells by analyzing the tumor microenvironment with spatial and single-cell resolution.

7 citationstop 5%

humanbulk RNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintJan 31, 2025

Heterochromatin fidelity is a therapeutic vulnerability in lymphoma and other human cancers

Mohamad Ali Toufic Najia, Deepak Kumar Jha, Cheng Zhang…·George Q. Daley

The paper identifies KDM4 demethylase inhibition as a therapeutic strategy for lymphoma and other cancers by rewiring heterochromatin and inducing DNA damage.

1 citation

humanChIP-seq

𝕏 PostBluesky